GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach
People with certain chronic conditions are faring worse than others during the pandemic. A new survey from The Harris Poll commissioned by GlaxoSmithKline finds that people with asthma, specifically severe eosinophilic asthma, are among them.
More than two-thirds (68%) of patients diagnosed with severe eosinophilic asthma surveyed describe their health as fair or poor – and that may be downplaying the reality. Ninety percent of physicians who see severe asthma patients surveyed rate their patients’ overall quality of life using the same fair or poor descriptors.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
